Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Xiaoying Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4633-8368; OpenAlex author ID A5101748183. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Stress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-24-0785↗
  2. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Co-author DOI 10.1038/s41598-023-43498-9↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaroslav Teper · 2 shared papers, 2023–2025 · strength 0.45
  2. James W. Sinnett‐Smith · 2 shared papers, 2023–2025 · strength 0.45
  3. Guido Eibl · 2 shared papers, 2023–2025 · strength 0.45
  4. Enrique Rozengurt · 2 shared papers, 2023–2025 · strength 0.45
  5. Oscar Joe Hines · 2 shared papers, 2023–2025 · strength 0.45
  6. Aurelia Lugea Reta · 1 shared paper, 2023 · strength 0.18
  7. Linda Ye · 1 shared paper, 2023 · strength 0.18
  8. Richard T. Waldron · 1 shared paper, 2023 · strength 0.18
  9. Stephen Jacob Pandol · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.